Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Operator Access on Implant Surface Roughness Following Implantoplasty Procedures: A Laboratory Study.

Clinical and experimental dental research·2026
Same author

Latent Causal Diffusions for Single-Cell Perturbation Modeling.

ArXiv·2026
Same author

Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis.

German medical science : GMS e-journal·2025
Same author

Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.

German medical science : GMS e-journal·2025
Same author

Of Revolutions and Roadblocks: The Emerging Role of Machine Learning in Biocatalysis.

ACS central science·2025
Same author

Pulmonary Involvement in Autoimmune-Mediated Disease.

Deutsches Arzteblatt international·2025

Related Experiment Video

Updated: Jun 8, 2026

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

Visualization concepts to enhance quantitative decision making in drug development.

Kevin Dykstra1, Richard Pugh, Andreas Krause

  • 1Pharsight/Certara, Strategic Consulting Services, St. Louis, Missouri, USA. kevin.dykstra@qpharmetra.com

Journal of Clinical Pharmacology
|October 1, 2010
PubMed
Summary

Graphical presentation is key in pharmacometric analysis, guiding data exploration, model building, and simulation phases. Effective graphics improve communication and decision-making throughout modeling and simulation projects.

More Related Videos

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

Related Experiment Videos

Last Updated: Jun 8, 2026

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

Area of Science:

  • Pharmacometrics
  • Computational Biology
  • Data Visualization

Background:

  • Graphical presentation is essential for communicating pharmacometric analysis and simulation (M&S) results.
  • M&S projects involve distinct phases: exploratory data analysis, model building, and simulation, each with specific graphical needs.

Purpose of the Study:

  • To outline general considerations for effective graphical communication in M&S projects.
  • To provide example graphs illustrating graphical principles for each M&S phase.

Main Methods:

  • Describing general principles for graphical displays.
  • Illustrating these principles with example graphs.

Main Results:

  • Exploratory data analysis graphics aid in data quality assessment and relationship discovery.
  • Model building graphics focus on assessing model fit and qualification.
  • Simulation phase graphics highlight model implications for decision-making.

Conclusions:

  • Tailoring graphical presentations to specific M&S project phases enhances communication.
  • Well-designed graphics are crucial for understanding and decision-making in pharmacometrics.